“…Characterization of the processing of histone pre-mRNA derived from injected DNA+ A: The S1 nuclease protection assay used to measure histone pre-mRNA processing is diagramed+ The 260-nt probe contains 43 nt that are not present in the H2a-614 histone pre-mRNA, but are derived from the vector pBluescript KS (zig-zag line)+ The unprocessed RNAs protect a 217-nt fragment regardless of their 39 end and the processed histone mRNAs protect a 183-nt fragment+ Because the probe is 39-end labeled, the ratio of the intensity of the two fragments is a measure of processing efficiency+ B: Frog oocytes were preincubated in buffer (lane 2) or with 200 mg/mL Actinomycin D (lane 3) for 1 h+ They were then injected with the histone H2a-614 gene and blue Dextran, and incubated in the continued presence of the inhibitor for 18 h+ RNA was prepared and then assayed for histone H2a-614 mRNA+ Lane 1 is marker pUC18 digested with MspI+ C: Oocytes were injected with the H2a-614 gene and blue Dextran, incubated for 18 h and then half of the oocytes were harvested (lane 1) and the other half were incubated for an additional 5 h in 200 mg/mL Actinomycin D (lane 2)+ A separate batch of oocytes was injected with either the H2a-614 gene (lane 3) or with the histone H2a-4G gene (lane 4) and incubated for 18 h+ The H2a-4G gene produces a transcript that cannot be processed because of the insertion of four Gs at the cleavage site )+ RNA was prepared from the oocytes and RNA from the equivalent of one oocyte analyzed by S1 nuclease mapping+ D: Frog oocytes were injected with the histone H2a-614 gene and the levels of processed and unprocessed histone mRNAs measured 18 h later (lane 1)+ In lane 2, the human U7 gene (Jacobs et al+, 1999) was coinjected into the nucleus with the H2a-614 gene+ In lane 3 the oocytes were injected with synthetic xSLBP1 mRNA 30 h prior to injection of the histone H2a-614 gene+ In lane 4, the oocytes were injected with the xSLBP1 mRNA 30 h prior to coinjection of the human U7 gene and the histone H2a-614 gene+ The processing efficiency (percent processing) quantified using a PhosphorImager is indicated below each lane+ xSLBP1 and U7 snRNP cooperate to process histone pre-mRNA in vivo Histone pre-mRNA processing in oocytes requires both xSLBP1 (Wang et al+, 1999) and the U7 snRNP (Scharl & Steitz, 1996) as well as other factors+ A critical step in vitro is assembly of a stable complex containing SLBP and U7 snRNA on the histone pre-mRNA , and efficient assembly of the complex requires both stable binding (high affinity) of SLBP to the stem-loop and base-pairing of U7 snRNP to the pre-mRNA )+ To determine whether xSLBP1 or U7 snRNP were limiting for processing in vivo we increased the concentration of U7 snRNA by expressing U7 snRNA from the human U7 snRNA gene (Jacobs et al+, 1999) and the concentrations of xSLBP1 by injecting synthetic xSLBP1 mRNA+ There are excess snRNP proteins present in the frog oocyte that will assemble U7 snRNA into functional U7 snRNP particles (Strub & Birnstiel, 1986)+ In this experiment we used a batch of oocytes that processed the histone H2a-614 mRNA relatively inefficiently (Fig+ 1D, lane 1)+ Overexpression of either U7 snRNA or xSLBP1 resulted in an increased efficiency of processing (Fig+ 1D, lanes 2 and 3)+ Overexpression of both xSLBP1 and U7 snRNA in the same oocytes resulted in a further increase in processing (Fig+ 1D, lane 4)+ Thus both U7 snRNP and xSLBP1 are present at suboptimal concentrations for processing the histone H2a-614 pre-mRNA expressed in the oocyte+ This result is consistent with the suggestion that these two factors cooperate in histone pre-mRNA processing …”